Skip to content

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ranibizumab FER (ATC-Code nach WHO: S01LA04)

open

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

Read the notice at vergabe-de ↗

Value
unstated
Published
10 Nov 2026
Deadline
31 Dec 2027, 22:58 GMT
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDEG01

Description

Siehe Kurzbeschreibung

Key facts

Reference
164/2026-OH
Procedure
open
Lots
1
Contact
Geschäftsbereich Unternehmenssicherheit, Zentrale Vergabestelle
vergabestelle@plus.aok.de
+49 80010590-80071
Bids opened
31 Dec 2027, 22:59 GMT
Regime
publicSector
  • The documents — every attachment, with its text extracted and searchable
  • Qualification — the notice scored against your company profile
  • Tracking and alerts — a pipeline for your bids, and the matching notices by email
  • Calendar export — the deadline as a calendar file
  • The API and MCP — the same record in your own tools and your AI assistant

Provenance

Source
vergabe-de
Notice id
6d13e075-0b3b-4dd5-89bf-062e233c0c9e
OCID
ocds-mnwr74-ac744d43-4259-4b3b-9d0f-1b2ff2eab071
First seen
12 Nov 2026
Last updated
12 Nov 2026

Licence CC0 1.0 public domain dedication ↗

Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.

View at source ↗GET /api/v1/tenders/6f60a516-3abb-417b-8393-b2b508c1068c

The source notice is authoritative — verify deadlines and documents there before bidding.